Spec-Driven AI Development: Why Pharma Needs Formal Specifications Before Writing a Single Line of Code

The Real Reason AI Projects Fail in Pharma

It's rarely the algorithm. In our experience building AI systems for healthcare organizations, the failure pattern is almost always the same: a team builds a technically impressive model, but nobody defined what "good enough" means before development started.

The result? Months of iteration with no clear endpoint. Regulatory reviewers who can't evaluate a system that lacks defined acceptance criteria. Stakeholders who keep moving the goalposts because the goalposts were never planted.

What Is Spec-Driven Development?

Spec-Driven Development is a methodology where every AI system begins with a formal specification document before any code is written. The spec defines:

• •Success KPIs — measurable metrics that determine whether the system works (sensitivity ≥ 0.92, latency < 200ms, false positive rate < 5%)
• •Uncertainty measurement — how the system communicates confidence and handles edge cases
• •Validation protocols — the exact tests, datasets, and statistical methods used to verify performance
• •Failure modes — what happens when the system encounters inputs outside its training distribution
• •Boundary conditions — explicit scope of what the system does and does not do

This isn't waterfall. The spec is a living document that evolves — but it evolves through deliberate, documented decisions, not through drift.

Why Does Spec-Driven Development Matter for Pharma?

1. Regulatory alignment from day one

The EU AI Act (Art. 9-15)¹ and the FDA's guidance on AI/ML-based Software as a Medical Device (SaMD)² both require documented risk management, performance benchmarks, and validation evidence. A spec-driven approach generates this documentation as a natural byproduct of development — not as an afterthought.

2. Clinical validation becomes testable

When your spec says "the system must achieve ICC > 0.85 across three independent raters," validation isn't a philosophical debate. It's a test you run. Pass or fail. This is the same rigor we apply in clinical trials — why should AI development be any different?

3. Stakeholder alignment

A formal spec forces conversations about trade-offs early: "Do we optimize for sensitivity or specificity? What's the acceptable false negative rate for this patient population?" These decisions are better made in a meeting room than discovered in production.

4. Cost predictability

With defined acceptance criteria, you know when you're done. No more "let's try one more architecture" cycles that extend timelines indefinitely. In regulated environments, unpredictable timelines translate directly to unpredictable costs.

What a Spec Looks Like in Practice

A well-written spec for a healthcare AI system typically includes:

• •Input definition: Exact data formats, minimum quality thresholds (e.g., "VCF files, minimum 30x coverage")
• •Output schema: Typed outputs with classification categories and confidence scores
• •Success KPIs: Concrete metrics with thresholds (e.g., "≥ 95% concordance with reference standard")
• •Uncertainty protocol: What happens at low confidence (e.g., "flag for manual review if confidence < 0.7")
• •Validation plan: Statistical tests, dataset splits, and acceptance criteria defined before development
• •Failure modes: Explicit handling of out-of-distribution inputs (e.g., return "insufficient evidence" rather than a low-confidence prediction)

The key is that all of these are defined and agreed upon before writing code. This eliminates the ambiguity that causes projects to cycle through months of undefined "improvement."

How to Start

You don't need to overhaul your entire process. Start with these three questions before your next AI project:

• 1.What specific, measurable outcome defines success? (Not "improve diagnosis" — give me a number.)
• 2.What data will you use to prove it works? (Define the validation dataset and statistical test now.)
• 3.What happens when the system is wrong? (Design the failure path before you design the happy path.)

If you can't answer these three questions, you're not ready to write code. You're ready to write a spec.

The Bottom Line

In pharma, the cost of building the wrong thing is measured in years and millions. Spec-Driven Development doesn't slow you down — it prevents you from running fast in the wrong direction. The spec is your compass.

References

• 1.Regulation (EU) 2024/1689 — EU AI Act. Articles 9-15: Requirements for high-risk AI systems. Available at: eur-lex.europa.eu/eli/reg/2024/1689
• 2.U.S. FDA. Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. Available at: fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices

Building an AI system for pharma or healthcare? Our team helps define formal specifications, validation protocols, and success metrics before development begins. Let&#39;s talk.